November 05, 2018 02:54 PM
Updated on November 5, 2018. 16:09
Half of the nearly 10 million patients with active TB diagnosis each year can be cured with shorter treatments than currently recommended, according to a study published on Monday Natural medicine.
A new analysis from the University of California, San Francisco (UCSF) suggests that more accurate treatments could be more effective in treating a bacterial infection that kills 1.3 million people every year worldwide.
In a study led by Marjorie Imperial, a graduated pharmaceutical scientist at UCSF, they again analyzed data obtained in three tests that did not show the effectiveness of four-month treatments to alleviate this infection. lung attacks.
UCSE scientists have said that the reason for the failure of these tests is that all patients are treated the same way, regardless of the severity of their situation.
In a new study, patients were stratified retrospectively into three categories, depending on the condition of the disease: minimal, moderate and severe. A four-month drug treatment was very effective for 47% of patients with minimal illness.
However, for four months, they were not effective for patients in moderate or severe conditions.
"Our study shows that the stratified drug approach can be applied in a feasible way to achieve a shorter treatment for many tuberculosis patients," explains Paiam Nahid, MD, of the United States University of Medicine.
"This approach leads to poor treatment of patients with severe disease or excessive treatment of patients with less advanced diseases, as they receive drugs that can cause harm," Nahid added.
Tuberculosis was treated with antibiotics since the discovery of streptomycin in 1943.
Scientists have pointed out the danger of this situation as this is currently an infectious disease that kills more people in the world.